In order to get the GLP-1 weight loss drugs for $50 a month, patients will need to have optional Medicare Part D drug plans
NICE Technology Appraisal guidance (TA875 for semaglutide/Wegovy and TA664 for liraglutide/Saxenda) recommends these medications for weight management in adults with: A body mass index (BMI) of at least 35 kg/m and At least one weight-related comorbidity (such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or non-alcoholic fatty liver disease) For liraglutide (Saxenda), NICE TA664 specifies additional criteria including prediabetes (HbA1c 42-47 mmol/mol or fasting plasma glucose 5.5-6.9 mmol/L) or high risk of cardiovascular disease
Magnesium and Movement: Clearing the "GLP-1 Clog" If youre on the opposite end of GI side effects and things arent moving in the gut, magnesium is how to fix GLP-1 constipation
Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children
29.Prado CM, Phillips SM, Gonzalez MC, Heymsfield SB